Rajiv De Silva

Overview Venus Concept2 Valeant Pharmaceuticals International2

2011 2010

2010 - Valeant Pharmaceuticals International

In 2010, Rajiv De Silva earned a total compensation of $3M as President and Chief Operating Officer, Specialty Pharmaceuticals at Valeant Pharmaceuticals International.

Compensation breakdown

Non-Equity Incentive Plan	$192,500
Option Awards	$1,110,000
Salary	$163,958
Stock Awards	$1,514,700
Other	$807
Total	$2,981,965

De Silva received $1.5M in stock awards, accounting for 51% of the total pay in 2010.

De Silva also received $192.5K in non-equity incentive plan, $1.1M in option awards, $164K in salary and $807 in other compensation.

Rankings

In 2010, Rajiv De Silva's compensation ranked 2,009th out of 10,439 executives tracked by ExecPay. In other words, De Silva earned more than 80.8% of executives.

Classification	Ranking	Percentile
All	2,009 out of 10,439	81st
Division Manufacturing	700 out of 3,838	82nd
Major group Chemicals And Allied Products	137 out of 921	85th
Industry group Drugs	78 out of 680	89th
Industry Pharmaceutical Preparations	61 out of 481	87th

Source: SEC filing on April 30, 2012.

2011

De Silva's colleagues

We found eight more compensation records of executives who worked with Rajiv De Silva at Valeant Pharmaceuticals International in 2010.